Molecular Cancer Therapeutics (Journal)

Van Schaeybroeck, S. (Peer reviewer)

Activity: Publication peer-review and editorial work typesPublication peer-review

Description

Mutant-selective irreversible EGFR inhibitor, naquotinib, inhibits tumor growth in NSCLC models with EGFR activating mutations, T790 mutation and AXL overexpression
Period25 Sep 2018
Type of journalJournal
ISSN1535-7163